<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>医药前途汇 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-07T16:22:15+08:00</updated>
  <subtitle>「前途汇」通过网络和线下聚会：分享和传报全球医药行业信息资讯、技术项目、并购资源、代理品种。建立医药行业国际化的沟通桥梁、交易平台、学习园地。是中国医药行业人脉拓展、商务交流的“好圈子”。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>2021年值得开发的新药/仿制药推荐之“神经系统用药”系列（成熟技术）</title>
    <updated>2021-01-07T15:10:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/w8GZXEBY2IYYTaTrALXNyA</id>
    <link href="https://mp.weixin.qq.com/s/w8GZXEBY2IYYTaTrALXNyA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【转让】不用做临床的儿童新药--复方聚乙二醇电解质散（儿童型）</title>
    <updated>2021-01-07T15:10:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/ZuoHCa8ogeHgzSnOybNb8A</id>
    <link href="https://mp.weixin.qq.com/s/ZuoHCa8ogeHgzSnOybNb8A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【资金规模缩水】盘点2020年全球生物医药领域十大并购事件</title>
    <updated>2021-01-06T15:58:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-06:/s/ql3UWp4wgffhATL4-GEtoQ</id>
    <link href="https://mp.weixin.qq.com/s/ql3UWp4wgffhATL4-GEtoQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【CRO会员】北京海步医药API关联及制剂技术转让“项目推荐”</title>
    <updated>2021-01-06T15:58:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-06:/s/yyketHEXpOXyez07hIYa6Q</id>
    <link href="https://mp.weixin.qq.com/s/yyketHEXpOXyez07hIYa6Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【分论坛邀请函】双循环格局下药企的开放式创新（药智网）</title>
    <updated>2021-01-06T15:58:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-06:/s/nLJ-9_j9Po866mxTEK63rA</id>
    <link href="https://mp.weixin.qq.com/s/nLJ-9_j9Po866mxTEK63rA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药品代理商如何成为产品持有人？案例分析来了</title>
    <updated>2021-01-05T15:26:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-05:/s/xMcXN92ntP7Gt0DKFUSc1g</id>
    <link href="https://mp.weixin.qq.com/s/xMcXN92ntP7Gt0DKFUSc1g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【CRO会员】上海博志研新可合作“新药项目”推荐</title>
    <updated>2021-01-05T15:26:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-05:/s/h_-d5l6H4v6fH7ryaNarDg</id>
    <link href="https://mp.weixin.qq.com/s/h_-d5l6H4v6fH7ryaNarDg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【盘点】2021年Q1即将获批重磅药物</title>
    <updated>2021-01-04T15:58:25+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-04:/s/C7SY-P1m_Hf2pvjVGLirWg</id>
    <link href="https://mp.weixin.qq.com/s/C7SY-P1m_Hf2pvjVGLirWg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>拥有6大生产基地：京新药业可提供国际标准的口服固体制剂CMO服务</title>
    <updated>2021-01-04T15:58:25+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-04:/s/j0rppr5ss7Et3_BmxrP9QA</id>
    <link href="https://mp.weixin.qq.com/s/j0rppr5ss7Et3_BmxrP9QA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【药学CRO】智恒医药可合作“新药项目”推荐！</title>
    <updated>2021-01-04T15:58:25+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-04:/s/KEfs__xXTlTozXtDg9eo5A</id>
    <link href="https://mp.weixin.qq.com/s/KEfs__xXTlTozXtDg9eo5A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国家药监局：又有207个药品注册证书被注销</title>
    <updated>2020-12-30T15:16:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/BOiiwVqeF0rnu7lzdTW8pw</id>
    <link href="https://mp.weixin.qq.com/s/BOiiwVqeF0rnu7lzdTW8pw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【新药技术转让】日本原研治疗骨质疏松的“米诺膦酸片”已完成中试</title>
    <updated>2020-12-30T15:16:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/LLEgq2lxicslcS-zY9ZHvw</id>
    <link href="https://mp.weixin.qq.com/s/LLEgq2lxicslcS-zY9ZHvw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【盘点】2020年批准的9个国产1类新药（多款首创）</title>
    <updated>2020-12-29T12:59:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/FEkSCS_fTgcJ3EepPL_TiA</id>
    <link href="https://mp.weixin.qq.com/s/FEkSCS_fTgcJ3EepPL_TiA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>二合一降糖药市场巨大！4个“二甲双胍复方制剂”MAH合作</title>
    <updated>2020-12-29T12:59:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/ZtHQ84qeTN_-dsBeQ1S8NA</id>
    <link href="https://mp.weixin.qq.com/s/ZtHQ84qeTN_-dsBeQ1S8NA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【新会员】海药股份--可承接多种剂型的药品委托生产服务</title>
    <updated>2020-12-29T12:59:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/17IRNWlDj-4KN80eP8mJHQ</id>
    <link href="https://mp.weixin.qq.com/s/17IRNWlDj-4KN80eP8mJHQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>《焦点访谈》：医保目录如何进？为何出？</title>
    <updated>2020-12-29T12:59:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/tgUvu_o5XntOMydaJunE_Q</id>
    <link href="https://mp.weixin.qq.com/s/tgUvu_o5XntOMydaJunE_Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>降！降！降！2020版医保目录出炉（附名录）</title>
    <updated>2020-12-28T11:10:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/uB-TPK7EIdMUnK-wPATnfg</id>
    <link href="https://mp.weixin.qq.com/s/uB-TPK7EIdMUnK-wPATnfg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【药学CRO】天津汉康医药可合作新药项目推荐</title>
    <updated>2020-12-28T11:10:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/prpfAp1vt45TlAyHImVNgg</id>
    <link href="https://mp.weixin.qq.com/s/prpfAp1vt45TlAyHImVNgg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>大品种推荐：碳酸钙D3片/咀嚼片/颗粒技术成熟，免BE，接受再开发</title>
    <updated>2020-12-28T11:10:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/KkqIaPxRKzBlfD3hEGbvGw</id>
    <link href="https://mp.weixin.qq.com/s/KkqIaPxRKzBlfD3hEGbvGw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【中药大政策】促进已上市中药质量竞争，支持同名同方药的研制</title>
    <updated>2020-12-26T19:29:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-26:/s/FkP6lyQii7oa9PbPUvSYTQ</id>
    <link href="https://mp.weixin.qq.com/s/FkP6lyQii7oa9PbPUvSYTQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>